Moderna creates new executive committee role ahead of new product launches

Juan andres appointed to president, strategic partnerships and enterprise expansion jerh collins joins moderna as chief technical operations and quality officer to succeed juan andres cambridge, ma / accesswire / september 29, 2022 / moderna, inc., (nasdaq:mrna) a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines today announced that the company has expanded the executive committee to prepare for multiple upcoming new product launches. effective january 1, 2023, juan andres will step into a new role as president, strategic partnerships and enterprise expansion, and will focus on building out the organization to support the growing pipeline.
MRNA Ratings Summary
MRNA Quant Ranking